Christopher S Downs insider trades: CNS Pharmaceuticals (CNSP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP | ↑ Buy | 66,666 | $0.30 | $20K | Direct | Feb 6, 2024 (5d) |
| Aug 22, 2023 | CNSP | ↑ Buy | 27,000 | $1.27 | $34K | Direct | Aug 23, 2023 (1d) |
| Apr 17, 2023 | CNSP | ↑ Buy | 3,100 | $3.20 | $10K | Direct | Apr 18, 2023 (1d) |
| Dec 6, 2021 | CNSP | ↑ Buy | 5,000 | $0.94 | $5K | Direct | Dec 7, 2021 (1d) |
| Nov 19, 2021 | CNSP | ↑ Buy | 4,500 | $1.15 | $5K | Direct | Nov 22, 2021 (3d) |
| Aug 24, 2020 | CNSP | ↑ Buy | 142,000 | $2.04 | $290K | Direct | Aug 25, 2020 (1d) |
| Aug 14, 2017 | INFU | ↑ Buy | 7,900 | $1.90 | $15K | Direct | Aug 16, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CNSP insiders
Open-market trades in the last 12 months
About Christopher S Downs's insider trades
Christopher S Downs is Chief Financial Officer at CNS Pharmaceuticals (CNSP). Since Aug 14, 2017, Christopher has reported 7 open-market purchases worth $379K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.